Page last updated: 2024-11-01

nimodipine and Infection

nimodipine has been researched along with Infection in 2 studies

Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pointillart, V1
Petitjean, ME1
Wiart, L1
Vital, JM1
LassiƩ, P1
ThicoipƩ, M1
Dabadie, P1
Deaciuc, IV1
Spitzer, JA1

Trials

1 trial available for nimodipine and Infection

ArticleYear
Pharmacological therapy of spinal cord injury during the acute phase.
    Spinal cord, 2000, Volume: 38, Issue:2

    Topics: Acute Disease; Adult; Calcium Channel Blockers; Drug Therapy, Combination; Humans; Infections; Methy

2000

Other Studies

1 other study available for nimodipine and Infection

ArticleYear
Calcium content in liver and heart and its intracellular distribution in liver during endotoxicosis and sepsis in rats.
    Cell calcium, 1987, Volume: 8, Issue:5

    Topics: Animals; Calcium; Endotoxins; Escherichia coli; Infections; Liver; Male; Myocardium; Nimodipine; Per

1987